What it is
Thymosin alpha-1 is a peptide originally isolated from thymus tissue. It has been studied for its effects on immune cell function.
What the research says
- A comprehensive review of the literature summarized studies of thymosin alpha-1, including clinical studies in several conditions [1].
- A review described its immune-modulating effects [2].
Regulatory status
Thymosin alpha-1 is not FDA approved. Compounded versions are not FDA approved. Where prescribed, compounded versions are prepared by state-licensed 503A compounding pharmacies.
Safety and side effects
It acts on the immune system, and the reviews cited do not establish the safety of compounded thymosin alpha-1 [1][2]. A licensed healthcare provider should review your history and medications carefully, especially immune-related conditions.
Is it right for you?
Only a licensed healthcare provider can decide whether any treatment is appropriate for you.
Frequently asked questions
What has thymosin alpha-1 been studied for?
Immune modulation in research and clinical studies [1][2]. This page makes no claim about any illness.
Is thymosin alpha-1 approved by FDA?
No. Thymosin alpha-1 is not FDA approved. Compounded versions are not FDA approved.
Do I need a prescription for Thymosin Alpha-1?
Yes. Prescription only, requires evaluation by a licensed provider. A provider decides whether it is appropriate for you.
Sources
- Dominari A, et al. Thymosin alpha 1: a comprehensive review of the literature. World J Virol, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7747025/
- King R, Tuthill C. Immune modulation with thymosin alpha 1 treatment. Vitam Horm, 2016 (PubMed 27450734). https://pubmed.ncbi.nlm.nih.gov/27450734/
Thymosin Alpha-1 content on this page is for education. Compounded medications are not FDA approved. Prescription only, requires evaluation by a licensed provider. Educational content only, not medical advice.